Bristol-Myers Squibb was off to what seemed like it was going to be a great day in the market today. At the opening bell, the stock was trading in the green. After the bell, we saw a continuation of upward movement, …
Bristol-Myers Squibb
Lung cancer might not be the most common malignancy, but it is the deadliest. That is why Merck and Bristol-Myers have been fighting tooth and nail to get their PD-1 checkpoint inhibitors, Keytruda and Opdivo, to the …
The Motley Fool
Bristol-Myers Squibb Co. BMY, +0.66% shares sunk 7.2% in pre-market trade Friday after the company said …
Lung cancer
Shares of Bristol-Myers Squibb Company (NYSE:BMY) fell 2.5% on Friday after the company announced weaker than expected quarterly earnings. The company traded as low as $46.01 and last traded at $48.01, with a …
Middle East
Bristol-Myers shares jumped 3% yesterday after a late-stage study on cancer drug Opdivo proved to be a success, leading to Deutsche Bank raising its price target on the company’s stock Bristol-Myers Squibb Co …
Cowen and Company cut shares of Bristol-Myers Squibb Company (NYSE:BMY) from an outperform rating to a market perform rating in a report released on Friday morning. They currently have $65.00 target price on the …
Bristol-Myers Squibb
Sector Gamma As increased its stake in Bristol Myers Squibb Co (BMY) by 224.37% based on its latest …
Bristol-Myers Squibb
Last year was not friendly to pharmaceutical stocks. This was evident as the iShares NASDAQ Biotechnology Index (ETF) (NASDAQ: IBB) was a political rag doll that resulted in incredible chop trading. Bristol-Myers
NASDAQ1mon
Bristol-Myers Squibb
Shares of Bristol-Myers Squibb Co. (ticker: BMY) fell more than 16 percent Friday after the company announced that its Opdivo drug failed a study that would have expanded its use to lung cancer patients. BMY stock
USNews6mon
Bristol-Myers Squibb
First, the change in the U.S. political leadership has created some uncertainty. Bristol-Myers Squibb’s stock fell nearly 5% on January 11th when the new president Donald Trump announced that he would force the industry …
Trefis1mon
Bristol-Myers Squibb